The Dutch Healthcare Authority (NZa) has unveiled its second release of the Diagnosis Related Group (DRG) package for 2024, impacting specialist medical care and geriatric rehabilitation care. The package introduces notable additions, including a new procedure code and supplementary payments.
The introduced procedure code 050524, titled “Pathological examination – predictive immunohistochemical diagnosis in the context of therapy,” is designed for immunohistochemical assessments of protein expression in tissues, aiding in predicting treatment outcomes.
Additionally, two new supplementary payments (OZPs) are set to be incorporated: 039866 for “Urine tumor marker tests” and 192160 for “Perfusion for DCD heart donation (donation after circulatory death) with oxygen-rich blood.”
The update also caters to the unique healthcare needs of Adolescents and Young Adults (AYA) aged 18 to 39 diagnosed with cancer. Several new DRGs tailored to AYA care, such as DRG 219799033 and DRG 219799035, will be introduced to accommodate outpatient clinic visits and consultations for complex age-related AYA cancer care.
AYA care focuses on the distinct medical and psychosocial requirements of young adults, addressing concerns related to fertility, career development, and relationships due to their life stage.
These changes will come into effect on January 1, 2024, offering enhanced healthcare solutions and diagnostic tools for patients and medical professionals in the Netherlands.
This article has been prepared with the assistance of AI and reviewed by an editor. For more details, please refer to our Terms and Conditions. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author.
